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Abstract 
 
DCIS is a non-invasive breast cancer, increasingly detected through routine breast 
screening.  Patients are reassured that the condition is early and not life-threatening but they 
undergo surgery similar to that used in the treatment of invasive breast cancer (IBC).  Little 
research has explored the psychosocial impact of DCIS, especially in the UK.  A 
longitudinal, prospective study was therefore conducted to address this gap.  Fifty women 
newly diagnosed with DCIS were followed over the first year post-diagnosis.  Anxiety and 
depression significantly reduced from baseline to 6 months.  Body image distress was 
relatively stable, but extensive for some women.  Those undergoing mastectomy with 
immediate reconstruction experienced significantly greater body image concerns.  This 
study highlights that DCIS patients can experience psychosocial distress that is often 
transient but in some cases extensive and prolonged.  Appropriate psychosocial support is 
needed to help DCIS patients adjust to the diagnosis, its treatment and long-term 
implications.   
 
Keywords: Ductal carcinoma in situ (DCIS); psychosocial impact; anxiety; 
depression; body image distress. 
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Introduction 
 
Ductal carcinoma in situ (DCIS) is a non-invasive breast condition which is increasingly 
detected by routine breast screening.  In the UK 3,168 women were diagnosed with DCIS 
from 2006/07, which represents approximately 20% of UK screen-detected breast cancers. 
1, 2
  DCIS cells are confined to the ducts of the breast 3 and although evidence suggests it 
can progress to invasive breast cancer (IBC), controversy surrounds its natural history.4  
Some clinicians and researchers emphasise that because the majority of DCIS is high grade 
(which has a greater risk of progression), detection and treatment of DCIS is required, 5 
which could also reduce the incidence of IBC.6  However, others are critical of breast 
screening and maintain that the rise in DCIS detection constitutes an overdiagnosis,7 that 
many cases would never develop into clinically life-threatening IBC during the patient’s 
lifetime and that screening therefore causes patient harm rather than benefit.8  A further 
challenge for patients is that although they are typically reassured that their DCIS has been 
caught early and is not life-threatening, they are often offered the same treatment options 
(e.g. surgery, radiotherapy, hormone therapy) as those treated for IBC.9   
 
These issues and debates have recently been intensified by a review of publicly organised 
screening programmes arguing that overdiagnosis is high 10 and that some women undergo 
unnecessary treatment.  This work has generated numerous highly-charged contesting 
articles, letters and media reports about the benefits, or otherwise, of screening.  
Furthermore, Gøtzsche and others emphasise that the information given to women invited 
for screening requires improvement because it does not mention overdiagnosis or the 
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possibility of detecting DCIS.11-13  Importantly, as these debates filter into the public 
domain, they may impact upon healthy women’s concerns and decision making in relation 
to breast screening, as well as affecting those currently or previously diagnosed and treated 
for DCIS.    
 
Therefore, against the backdrop of controversies and diverse opinions about DCIS, it is 
vital to understand the psychosocial impact of the condition in order to inform the provision 
of appropriate care, support and information.  However, there is a paucity of research in this 
area.14  Some evidence suggests that patients adjust and recover relatively easily.15, 16  
However, others indicate that, despite the relatively positive prognosis,17 DCIS patients can 
have levels of distress comparable to those diagnosed with IBC 18-20 and hold inflated 
perceptions of the risk of the condition.19, 21  Additionally, a few qualitative studies have 
highlighted the confusion and uncertainty about DCIS amongst previously diagnosed 
women.22, 23  However, the bulk of this previous research has been retrospective in nature - 
conducted some months post-treatment.  Early experiences following diagnosis have not 
been explored.  One recent prospective study was conducted in the United States 24  but to 
date no published UK research has prospectively examined the psychosocial impact of 
DCIS.  Such research is important because treatment practices and views about DCIS differ 
across healthcare systems and health professionals in different countries. 25-27  Finally, the 
DCIS literature has rarely explored the potential psychosocial impact of the surgery 
undergone by DCIS patients.  The current study therefore aimed to address the gaps in the 
existing literature by prospectively exploring the psychosocial impact of DCIS amongst UK 
patients during the first year following diagnosis.  
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Materials and methods 
 
Participants and recruitment 
Ethical approval was obtained from Southmead Hospital NHS Ethics Committee (Bristol) 
and the R&D department in each NHS site.  Nine breast clinics in the UK (primarily in the 
South-West) were involved in recruiting eligible patients.  The study commenced at 5 sites 
in January 2007, whereas the latter clinics joined the study in September 2007.  
Recruitment continued until February 2008.  Women were eligible if they had an initial 
biopsy diagnosis of DCIS (without evidence of invasion), had not yet completed surgical 
treatment or had undergone surgery within the previous 3 months, had no serious co-
morbidity, and a fluent comprehension of English (due to the study methods and a lack of 
translating facilities).  Women with a recurrence of DCIS were excluded. 
 
Eligible women were introduced to the study by their breast care nurse (BCN), who also 
obtained their agreement to release their contact details to the researcher (FK).  Written 
informed consent was obtained from all women at each data collection point.  Overall, 50 
women participated in the study (80.6% participation rate of 62 women whose contact 
details were provided to the researcher).  Unfortunately 7 women were diagnosed with IBC 
following surgery, and were excluded from the analysis in this paper, leaving 43 
participants in this analysis.  One woman was lost to follow-up at 9 months and was 
excluded from the longitudinal analyses.  The 12 women who declined cited difficulty 
coping, no problems or a preference not to take part.   
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Questionnaires 
Participants completed the following standardised questionnaires near to diagnosis, and at 6 
and 9 months post-diagnosis:  
- Hospital Anxiety and Depression Scale (HADS) 28 - a screening tool for anxiety and 
depression (7 items each).  Scores of 8 - 10 are suggestive of ‘borderline’ problems, 
whilst equal or greater than 11 indicate substantial ‘case’ anxiety or depression 
which may benefit from psychological support.   
- Body Image Scale (BIS) 29- assesses cancer patients’ body image distress.  Scores 
range from 0 - 30, with a higher score indicating greater distress.  Hopwood et al. 30 
suggest scores of 11 or more should be considered a priority for help.    
- European Organisation for Research and Treatment of Cancer Quality of Life 
Questionnaire (EORTC QLQ-C30 version 3) 31, 32 - assesses QoL in cancer patients.  
The global subscale was utilised to measure overall QoL, and a higher score 
represents healthy functioning.  
 
Data Analysis Plan 
An a priori power calculation using anxiety as the primary dependent variable was 
undertaken with the aim of having a sample size sufficiently large enough to detect a 
clinically meaningful medium effect with at least 80% power (α = 0.05, 2.0≤β ).  For an 
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analysis using a Bonferroni corrected pairwise application of the paired samples t-test to 
detect a longitudinal change in mean anxiety a sample size of n = 45 would be needed.   
 
Data were analysed using SPSS (version 17).  A series of separate one-way doubly-
multivariate repeated measures analysis of variance (ANOVA) 33 were used to investigate 
changes in psychosocial measures (anxiety, depression, body image, QoL) over time and to 
assess potential systematic differences in these measures according to the between-subjects 
effects of type of surgery (wide local excision (WLE), mastectomy, mastectomy with 
reconstruction), method of detection (screen-detected, symptomatic), whether received 
radiotherapy or hormone treatment.  Separate analysis of variances from a one-way 
repeated measures design was undertaken for each dependent variable, along with 
Bonferroni (or equivalent) corrected paired t-tests (two-tailed), to located precise 
differences whilst preventing the over capitalisation of Type I errors that may arise from the 
multiplicity of testing.  
 
Prior to analysis a screening of the dependent variables using the Mahalanobis distance and 
an assessment of the residuals using Cook’s distance indicated that there were no discrepant 
outlying or overly influential response profiles amongst respondents.  An assessment of 
residuals using the Kolmogorov-Smirnov test indicated there were no gross departures from 
normality p ≥ 0.05 in all cases.  Mauchly’s test of sphericity was used to determine 
whether the repeated measures analysis of variance should proceed using standard F-tests 
or the epsilon adjusted Greenhouse-Geisser F-tests.33, 34   
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Results 
 
Participant characteristics 
The 43 women ranged between 34 and 87 years old (mean 60.2). Most were in a 
relationship (70%), diagnosed through routine screening (n = 33; 76.7%), and completed 
the baseline questionnaire approximately 44.7 days post-diagnosis (sd = 29, range 8 – 113).  
Table 1 presents the surgery details.  Additionally, 12 underwent radiotherapy and 9 
received hormone treatment. 
 
Psychosocial impact over time 
Table 2 presents the percentage of participants reporting HADS anxiety and depression 
scores above the cut-off scores.  Overall, the incidence of anxiety 'caseness' reduced over 
time, but 2 women consistently remained at case or borderline level, 2 worsened, and 5 
improved at 6 months but worsened at 9 months.  Depression scores showed a similar 
pattern; one woman consistently reported a 'case' level of depressive symptoms, one 
worsened and one improved at 6 months but then reverted to 'case' level).  Eight women 
(18.6%) reported no body image concerns at any point during the study.  Using a cut-off 
score of 11, 30.2%, 20.9% and 19% of participants indicated considerable body image 
distress at baseline, 6 months and 9 months respectively.   
 
Application of a one-way doubly multivariate repeated measures ANOVA revealed 
multivariate statistically significant changes over time in the linear combination of the four 
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dependent variables: Pillai’s trace = 0.43, Multivariate F8, 32 = 3.04, p = 0.01.  Bold type in 
Table 3 presents the values of each measure at each time point (n = 42, due to the attrition 
of 1 participant).   
 
Follow-up one-way repeated measures ANOVAs for each variable found significant results 
for anxiety and depression: F2, 78 = 14.88, p < 0.001, and F1.69, 66.05 = 8.55, p = 0.001.  
Subsequent post-hoc paired samples t-test showed a significant reduction in anxiety (p < 
0.001) and depression (p = 0.003) from baseline to 6 months, and baseline to 9 months 
(anxiety p < 0.001; depression p = 0.01), but no significant mean changes from 6 to 9 
months.  This indicates a reduction in anxiety and depression from baseline to 6 months, 
which is maintained at 9 months.  Neither body image nor QoL differed significantly over 
time. 
 
Psychosocial impact by type of surgery 
Surgical group was entered as a between-subjects factor into the previous ANOVA 
(mastectomy, n = 10; mastectomy with reconstruction, n = 9; WLE, n = 23).  No 
multivariate time-by-surgery interactions were found, but the multivariate surgery effect 
was significant: Pillai’s trace = 0.41, Multivariate F8, 74 = 2.39, p = 0.02.   
 
Follow-up between-subjects analysis showed no difference between the surgical groups in 
anxiety or QoL.  The Games-Howell post-hoc test (which is more accurate when population 
variances differ 34, 35), showed no difference in levels of depression, which indicates the 
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initial significant result for depression (F2, 39 = 3.98, p = 0.027) may be due to the uneven 
groups and population variances.   
 
However, the surgical groups differed significantly in terms of body image distress: F2, 39 = 
7.37, p = 0.002.  Women who underwent an immediate reconstruction reported 
significantly greater overall body image distress than WLE patients (p = 0.001) and 
marginally (p = 0.055) higher levels than those who underwent mastectomy without 
reconstruction (Table 3).   The percentage reporting ‘priority’ levels of body image distress 
was also greatest amongst the immediate reconstruction group (Table 4). 
 
Additional analyses 
Similar separate ANOVAs were conducted with detection (screen-detected vs. symptom), 
radiotherapy and hormone treatment as between-subjects factors.  No significant between-
subject or multivariate interactions were found (Table 5), which indicates the method of 
detection and adjuvant treatment received were not overly influential factors on the 
psychosocial outcomes measured. 
 
Discussion 
 
This UK-based study provides a valuable insight into patterns of psychosocial distress 
during the first year post-diagnosis of DCIS.  Overall, most patients reported positive 
adjustment (evidenced by the significant reduction in anxiety and depression) but some 
experienced prolonged distress.  There was a clear effect of surgery on body image, in 
 11
which women who underwent mastectomy with immediate reconstruction reported 
significantly higher levels of distress. 
 
The early, prospective impact of DCIS has rarely been captured in previous research, 
especially in the UK.  Participants were recruited from multiple breast care centres and 
there was very little attrition.  However, the final sample was still relatively small and the 
use of Specialist BCNs to initially approach eligible participants may have incurred some 
selection bias.  Most existing research in this field has been retrospective and conducted 
some time post-treatment, which may have obscured women’s early experiences and the 
detail of changes over time.  The current study makes a substantial contribution by 
capturing the psychosocial impact of the period around diagnosis.  However, the complex 
nature of identifying and recruiting women with pure DCIS (e.g. no invasive disease) near 
to diagnosis meant that a pragmatic and sensitive approach was required.  Seven women in 
the initial sample were found to have IBC at surgery, and due to the relatively small sample 
these women were removed from the current analysis.  However, it is important that future 
research explores this subset of patients' psychosocial experiences in detail.   
 
Despite the caveats previously mentioned, the results support a recent large study (n = 487) 
of newly diagnosed DCIS patients in the United States,24 which reported a similar decrease 
in anxiety and depression over time.  However, the current study found considerably higher 
levels of anxiety and depression at baseline.  Although the US study by Partridge et al. 24 
might be considered more representative in terms of the large sample, the current study 
may more accurately reflect anxiety near to diagnosis (44.7 days post-diagnosis, sd = 29, 
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70% post-surgery, on average 4 weeks; versus 167.3 days post-diagnosis, sd = 60.8, and 
over 80% around 3 months post-surgery - Partridge, personal communication).  
Considerable levels of anxiety around the time of surgery have also been reported in 
patients diagnosed with IBC.36, 37  The high initial anxiety reported in the current study may 
relate to the more recent assimilation of the diagnosis and worries about either forthcoming 
treatment or post-surgical outcomes.  Interestingly, and similar to previous research, there 
was no significant difference in psychosocial outcomes according to the method of 
detection 38 or whether the women received radiotherapy or hormone treatment.39  
However, only a small number of outcomes were measured, and since this finding could be 
due to the sample size, future work needs to further investigate whether these variables are 
influential among women diagnosed with DCIS.  For example, being offered adjuvant 
treatment could prompt a greater negative risk perception of DCIS, leading to psychosocial 
distress in the absence of appropriate support. 
 
Partridge et al. 24 reported a significant reduction in distress from baseline to 18 months.  
The 6 month assessment in the current study gives an earlier indication that the difficult 
emotions experienced near to diagnosis often reduce within the first year, as has also been 
reported in IBC research.37, 40, 41  Interestingly, 9 month anxiety levels increased slightly 
(although not significantly), possibly because at this point women were typically awaiting 
their first mammogram post-diagnosis, which is reportedly a source of considerable and 
ongoing anxiety for IBC patients.42, 43  It has recently been reported that DCIS patients’ 
adherence to follow-up screening reduces over time,44 however to date research has not 
explored DCIS patients’ feelings about this.    
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Similar to Partridge et al, the current study found no discernible changes in QoL over time.  
However both studies used generic tools to measure QoL and it is possible that condition-
specific measures may be more sensitive to the unique impact of DCIS upon QoL.  Overall, 
the psychosocial measures used are well validated, standardised tools used extensively in 
breast cancer research.  However, since these measures were distributed at discrete time 
points they might not capture the complexity of women’s experiences.  For this reason, 
women in the current study also took part in semi-structured interviews, which are reported 
elsewhere.45 
 
Levels of body image distress were relatively stable over time, indicating the enduring 
nature of these concerns.   Women undergoing mastectomy with immediate reconstruction 
reported significantly greater body image distress.  No prior research has specifically 
examined the psychosocial impact of immediate reconstruction after mastectomy following 
diagnosis of DCIS.  A large population study 20 ‘early in the treatment recovery period’ 
(p.1476) supports the current results, although the exact time since diagnosis is unclear.  
Their sample comprised both DCIS (n = 555, 44%) and IBC patients, and the analysis 
showed no differences between the diagnostic groups.20  Previous work with IBC patients 
undergoing mastectomy with or without reconstruction (immediate and delayed) has not 
demonstrated the widely assumed psychosocial benefits of breast restoration.40  Greater 
distress among reconstruction patients may be due to a longer recovery period and the 
likelihood of requiring several operations to gain an acceptable aesthetic outcome.20, 40 
Furthermore, incorporating the reconstructed breast into a patient’s body image is a 
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considerable psychological task which is likely to still be in progress 9 months post-
diagnosis.   Women opting for immediate reconstruction may have a greater investment in 
their body image prior to diagnosis and higher expectations of the aesthetic outcome, 
which, if unmet, could evoke distress and dissatisfaction.46, 47  Finally, previous qualitative 
work has indicated that women find the paradox between the diagnosis of early, non-
invasive disease and extensive treatment (e.g. mastectomy) challenging,22 and this may be 
compounded when adjusting to breast reconstruction. 
 
Clearly some women with DCIS experience significant levels of distress both in the short 
and longer term.  The challenge is identifying those who are at risk of, or currently 
experiencing, this distress and how best to offer appropriate support.  This task has been 
acknowledged for some time by those treating IBC.37, 48   Previous DCIS research has 
proposed that levels of distress may be influenced by factors including confusion about the 
diagnosis, conflict resulting from the recommendation of extensive surgery and inaccurate 
risk perceptions.19, 22, 24  The present study did not explore whether women were aware of 
their risk (e.g. grade, Van Nuys prognostic index) and whether their perception of that risk 
influenced their psychosocial adjustment.  Prior research has argued that perceived risk of 
cancer is more strongly related to distress than objective indicators.49  This is an important 
question for future research, which has important implications for provision of care.24 
 
Providing appropriate support in clinical practice is difficult and requires additional time 
and training for professionals such as BCNs who are already often overstretched.  Although 
our findings suggest that women undergoing extensive surgery may be particularly 
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susceptible to heightened levels of distress, it is important that all DCIS patients are assured 
by clinic staff that support is readily available for them.   
 
In order to inform the provision of effective and appropriate care, further prospective 
research needs to examine the psychosocial impact of DCIS beyond the first year, including 
the issues of follow-up mammograms, body image distress, and patients’ experiences of 
reconstruction.    
 
Conclusion 
 
Whilst research continues to unravel the medical complexities of DCIS, the psychosocial 
distress experienced by patients diagnosed with the condition needs to be addressed.  The 
current study adds to the growing body of literature aiming to equip health professionals 
treating and caring for women diagnosed with DCIS to develop effective communication, 
information and support for patients.   
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Table 1 – Surgery details of the participants (n = 43) 
Characteristic Number (%) 
Surgery (awaiting or received) at baseline:  
WLE 
Mastectomy # 
Final surgery received at 9 months: 
WLE 
Mastectomy # 
Mastectomy with immediate reconstruction 
 
24 (55.8) 
19 (44.2) 
 
23 (53.5) 
11 (25.6) 
9 (20.9) 
 
# incl. 1 patient who underwent a bilateral mastectomy and 1 who at baseline had already undergone immediate reconstruction 
 
 
 
 
 
 
 
Table 2 – HADS cut-off caseness results 
 Baseline 6 months 9 months* 
Anxiety 0-7 22 (51.2%) 29 (67.4%) 28 (66.7%) 
Anxiety 8-10 4 (9.3%) 9 (20.9%) 9 (21.4%) 
Anxiety >10 17 (39.5%) 5 (11.6%) 5 (11.9 %) 
Depression 0-7 29 (67.4%) 39 (90.7%) 38 (90.5%) 
Depression 8-10 8 (18.6%) 2 (4.7%) 1 (2.4%) 
Depression >10 6 (14%) 2 (4.7%) 3 (7.1%) 
 
* n = 42 at 9 months 
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Table 3 – Mean (Sd) psychosocial distress scores according to time and surgery (n = 42) 
 Overall Baseline  6 months 9 months 
Anxiety a: * 
WLE 
Mastectomy 
Reconstruction 
 
5.75 (3.67) 
5.52 (4.46) 
9.11 (5.35) 
8.86 (6.00) 
8.39 (5.18) 
7.60 (6.60) 
11.44 (7.18) 
5.07 (4.73) 
4.78 (4.81) 
4.00 (3.43) 
7.00 (5.64) 
5.32 (4.40) 
4.09 (3.32) 
4.95 (4.75) 
8.89 (4.99) 
Depression a: * 
WLE  
Mastectomy 
Reconstruction 
 
2.57 (2.81) 
4.17 (3.26) 
6.30 (4.78) 
4.93 (5.04) 
3.39 (4.23) 
6.10 (5.53) 
7.56 (5.55) 
3.19 (3.44) 
2.22 (2.47) 
3.30 (2.83) 
5.56 (5.08) 
3.12 (3.68) 
2.09 (2.91) 
3.10 (2.64) 
5.78 (5.24) 
Body image a:  
WLE 
Mastectomy 
Reconstruction # 
 
3.75 (6.04) 
6.09 (5.82) 
13.10 (6.98) 
6.42 (7.88) 
4.28 (6.21) 
6.72 (7.90) 
11.54 (9.95) 
6.27 (7.49) 
3.57 (6.46) 
5.68 (4.54) 
13.83 (7.99) 
6.24 (7.74) 
3.39 (5.84) 
5.87 (7.69) 
13.93 (7.52) 
Global QOL b: 
WLE 
Mastectomy 
Reconstruction 
 
74.88 (14.81) 
76.11 (16.42) 
62.04 (15.90) 
71.43 (19.23) 
74.28 (16.65) 
75.00 (21.15) 
60.19 (21.15) 
72.22 (20.47) 
73.19 (20.71) 
76.67 (21.44) 
64.81 (21.15) 
73.61 (18.31) 
77.17 (16.52) 
76.67 (21.44) 
61.11 (15.02) 
 
* Significant main effect over time (p < 0.001).  #  Significant main effect for surgery (p = 0.001) 
a Scores range from 0 – 21 (or 0-30 in body image), lower score is preferable and indicates lower anxiety/depression/BI distress 
b Scores range from 0 - 100, higher score is preferable and indicates a higher level of quality of life 
 
 
 
 
 
 
Table 4 – Percentage of each surgery group reporting ‘priority’ body image distress scores 
 Baseline 6 months 9 months 
WLE (n = 23) 
Mastectomy (n = 10) 
Reconstruction (n = 9) 
16.7 
36.4 
62.5 
13.0 
18.2 
44.4 
8.7 
10.0 
55.6 
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Table 5 – Mean (Sd) psychosocial distress scores according to detection, radiotherapy and 
hormone treatment (n=42) 
 Overall Baseline 6 months 9 months 
Anxiety: 
Screen-detected (n=33) 
Symptomatic (n=9) 
Radiotherapy (n=12) 
No radiotherapy (n=30) 
Hormone therapy (n=8) 
No hormone therapy (n=34) 
 
6.82 (4.42) 
4.94 (4.18) 
6.94 (4.15) 
6.21 (4.53) 
6.50 (3.83) 
6.40 (4.56) 
 
9.52 (5.96) 
6.44 (5.68) 
10.50 (6.50) 
8.20 (5.77) 
9.50 (6.33) 
8.71 (6.01) 
 
5.36 (4.96) 
4.00 (3.84) 
5.33 (5.02) 
4.97 (4.69) 
5.00 (4.04) 
5.09 (4.93) 
 
5.58 (4.55) 
4.39 (3.92) 
5.00 (3.69) 
5.45 (4.71) 
5.00 (4.93) 
5.40 (4.35) 
Depression: 
Screen-detected 
Symptomatic 
Radiotherapy 
No radiotherapy 
Hormone therapy  
No hormone therapy 
 
3.97 (3.83) 
2.93 (2.90) 
3.50 (3.67) 
3.84 (3.70) 
3.21 (2.75) 
3.87 (3.85) 
 
5.12 (5.32) 
4.22 (4.06) 
5.00 (6.00) 
4.90 (4.72) 
4.88 (4.55) 
4.94 (5.22) 
 
3.45 (3.55) 
2.22 (2.95) 
2.75 (2.70) 
3.37 (3.72) 
2.88 (3.14) 
3.26 (3.55) 
 
3.33 (3.93) 
2.33 (2.60) 
2.75 (3.57) 
3.27 (3.78) 
1.87 (1.96) 
3.41 (3.95) 
Body image:  
Screen-detected 
Symptomatic 
Radiotherapy 
No radiotherapy 
Hormone therapy  
No hormone therapy 
 
6.20 (7.37) 
6.70 (6.38) 
4.59 (6.52) 
7.00 (7.30) 
4.51 (5.69) 
6.73 (7.40) 
 
6.18 (8.14) 
7.29 (7.20) 
5.93 (7.39) 
6.61 (8.18) 
5.14 (6.07) 
6.72 (8.29) 
 
6.26 (8.06) 
6.31 (5.26) 
4.00 (6.56) 
7.18 (7.74) 
3.25 (4.30) 
6.98 (7.94) 
 
6.17 (7.78) 
6.49 (8.05) 
3.83 (6.18) 
7.20 (8.18) 
5.13 (8.53) 
6.50 (7.66) 
Global QOL: 
Screen-detected 
Symptomatic 
Radiotherapy 
No radiotherapy 
Hormone therapy  
No hormone therapy 
 
72.48 (16.93) 
72.22 (12.95) 
75.46 (13.07) 
71.20 (17.10) 
77.08 (12.92) 
71.32 (16.63) 
 
71.72 (20.62) 
70.37 (13.89) 
75.00 (18.12) 
70.00 (19.77) 
73.96 (18.60) 
70.83 (19.60) 
 
70.96 (21.16) 
76.85 (18.06) 
77.08 (19.50) 
70.28 (20.84) 
77.08 (18.77) 
71.08 (20.95) 
 
74.75 (17.61) 
69.44 (21.25) 
74.31 (13.04) 
73.33 (20.22) 
80.21 (11.73) 
72.06 (19.34) 
 
